NBIX returns by year
Neurocrine Biosciences Inc. has returned +9.1% annually (CAGR) since 1997. Calendar-year, monthly and weekly total returns for Neurocrine Biosciences Inc. (NBIX) below, through August 13, 2026 — the most recent year is year-to-date.
Neurocrine Biosciences Inc. returns by year (1997–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $141.83 | $150.80 | +0.0% | +6.3% | |
| 2025 | $136.50 | $141.83 | +0.0% | +3.9% | |
| 2024 | $131.76 | $136.50 | +0.0% | +3.6% | |
| 2023 | $119.44 | $131.76 | +0.0% | +10.3% | |
| 2022 | $85.17 | $119.44 | +0.0% | +40.2% | |
| 2021 | $95.85 | $85.17 | +0.0% | -11.1% | |
| 2020 | $107.49 | $95.85 | +0.0% | -10.8% | |
| 2019 | $71.41 | $107.49 | +0.0% | +50.5% | |
| 2018 | $77.59 | $71.41 | +0.0% | -8.0% | |
| 2017 | $38.70 | $77.59 | +0.0% | +100.5% | |
| 2016 | $56.57 | $38.70 | +0.0% | -31.6% | |
| 2015 | $22.34 | $56.57 | +0.0% | +153.2% |
Total return by period
Methodology#
Returns are total returns (dividends reinvested), computed from NBIX's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is Neurocrine Biosciences Inc.'s average annual return?
- Since 1997, Neurocrine Biosciences Inc. (NBIX) has returned about 9.1% a year (the compound annual growth rate) and an average calendar-year return of 27.6%.
- What were Neurocrine Biosciences Inc.'s best and worst years?
- Over 1997–2026, the best year was 1999 (+260.0%) and the worst was 2006 (-83.4%).
- How often is Neurocrine Biosciences Inc. up in a year?
- 16 of the 29 full years since 1997 were positive — about 55% of the time.